Defect notification check
Class 4 Medicines Defect Notification: Star Pharmaceuticals Ltd, Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets, EL(26)A/48
Class 4 defect notification — Caution in use. Usually minor defects in packaging or other printed materials.
- Reference
- EL(26)A/48
- Issued
- 12 Nov 2026
- Marketing authorisation holder
- Star Pharmaceuticals Ltd
Scan for the official GOV.UK notice, or search GOV.UK for EL(26)A/48.
Pharmshark is not an official alerting route. Make sure your pharmacy receives alerts directly from the MHRA and through your organisation, and always act on the official GOV.UK notice. Printed from pharmshark.com on 21 November 2026; the notice may have changed since, so scan the QR code to check. Source: the MHRA on GOV.UK. Contains public sector information licensed under the Open Government Licence v3.0. Pharmshark is not affiliated with or endorsed by the MHRA.
No affected stock found
Batches as listed by the MHRA, exactly as published. Check against the GOV.UK notice before acting.
| Enalapril maleate/Hydrochlorothiazide 20 mg/12.5 mg Tablets EL(26)A/48 | |||||
|---|---|---|---|---|---|
| Batch number | Expiry | Pack size | Packs found | Action taken | Initials |
| Y018198 | 30/06/2027 | 28 | |||
| Y019635 | 31/10/2027 | 28 | |||
| C125483 | 29/02/2028 | 28 | |||
| C135541 | 30/11/2028 | 28 | |||
| Other packs found (write in) | |||||
|---|---|---|---|---|---|
| Product | Batch number | Expiry | Packs found | Action taken | Initials |
What needs to be done
- Note the Class 4 medicines defect notification for the batches listed in the notice.
- Continue to dispense this product; the notice says the quality of the tablets is not affected by the labelling defect.
- Pharmacists: if patients ask, reassure them that this is enalapril maleate 20 mg / hydrochlorothiazide 12.5 mg tablets as described in the Patient Information Leaflet (PIL).
- If a patient reports a suspected adverse reaction, advise that it should be reported via the MHRA Yellow Card scheme.
- Read and act on the official GOV.UK notice.
Pharmshark summary, checked by Chris Dotchin. It is not the official notice: always read and act on the GOV.UK notice.